| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 01/22/2009 | US20090023900 Anti-AlphaVBeta3 Recombinant Human Antibodies, Nucleic Acids Encoding Same |
| 01/22/2009 | US20090023749 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/21/2009 | EP2015744A2 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347615A Method for aggregating acetylcholinergic receptor for stabilizing neuromuscular junction |
| 01/21/2009 | CN101347568A Formulation of yam pills and quality control method |
| 01/21/2009 | CN100453530C Compounds and methods for inhibition of expression of VCAM-1 |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2366268C Pharmaceutical compositions for cns and other disorders |
| 01/20/2009 | CA2325633C Steroidal sapogenins and their derivatives for treating alzheimer's disease |
| 01/15/2009 | WO2009008727A2 Molecules for targeting compounds to various selected organs or tissues |
| 01/15/2009 | WO2009008725A2 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 01/15/2009 | WO2009008529A1 Antibody binding specifically to tdp-43 aggregate |
| 01/15/2009 | WO2008135661A3 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 01/15/2009 | WO2008077170A3 Benzothioamides, and use thereof for relaxing smooth muscles |
| 01/15/2009 | US20090018107 Novel composition to increase muscle strength |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018073 Administering polypeptide of growth factor to increase mitogenesis; bind to receptors and increase cell differentiation and survival |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090017138 Topical medicament |
| 01/15/2009 | US20090017136 Formulation to prevent and treat fibromyalgia, depression and other muscle and nervous system disorders |
| 01/15/2009 | US20090017127 once-daily oral administration relief of muscle spasm associated with painful musculoskeletal conditions over 24 hours; patient compliance, side effect reduction |
| 01/15/2009 | US20090017126 Modified Release Dosage Forms of Skeletal Muscle Relaxants |
| 01/15/2009 | CA2693742A1 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 01/15/2009 | CA2693048A1 Molecules for targeting compounds to various selected organs or tissues |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014281A1 Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. |
| 01/14/2009 | EP2013235A1 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency |
| 01/14/2009 | EP2013166A2 N-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use |
| 01/14/2009 | EP2012793A1 Use of a tricyclic compound for preparing a medicine for treating skeletal muscle degeneration |
| 01/14/2009 | EP2012792A1 Use of a compound inducing an increase of free serotonin rate in the body, for preparing a medicine for treating skeletal muscle degeneration |
| 01/14/2009 | EP1549741B1 Novel endothelial cells, antibodies against said cells and use thereof |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1423133B1 Treatment of muscular dystrophies and related disorders |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | EP1183049B1 Modification of biological elements |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP1107775B2 Composition containing pyrrolizidine-alkaloid-free petasites |
| 01/14/2009 | CN101342364A Medicament for treating lumbar muscle degeneration and preparation method thereof |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/14/2009 | CN100450475C Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | CA2385402C 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 01/13/2009 | CA2271276C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 01/08/2009 | WO2009005033A1 Agent for improving dysfunction due to neuropathy and rho kinase activation inhibitor |
| 01/08/2009 | WO2009004146A2 Novel herbimycin a analogue derivatives, compositions containing same and use thereof |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012126 Certain chemical entities, compositions, and methods |
| 01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
| 01/08/2009 | US20090012040 Biocompatible polymers, process for their preparation and compositions containing them |
| 01/08/2009 | US20090012027 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/08/2009 | US20090011985 Gh secretagogues and uses thereof |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP1824472B1 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 01/07/2009 | EP1474434B1 The eaat2 promoter and uses thereof |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1246835B1 Substituted sapogenins and their use |
| 01/07/2009 | CN101337109A Vehicle-mounted multifunctional physiotherapy equipment |
| 01/07/2009 | CN101337030A Medicine composition for reducing swelling and easing pain, preparation method and use thereof |
| 01/07/2009 | CN100448868C Tri-substituted heteroaryls and methods of making and using the same |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473679 Treatments employing neuronal exocytosis-inhibiting peptides |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/01/2009 | US20090005442 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/01/2009 | US20090005390 Novel quinuclidine derivatives and their use |
| 01/01/2009 | US20090005386 Methods for Modulating Ion Channels |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005313 Activatable clostridial toxins |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004235 Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals |
| 01/01/2009 | US20090004224 Activatable clostridial toxins |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2008140782A3 Compounds for enzyme inhibition |
| 12/31/2008 | EP2009011A1 Nitrogen-containing heterocyclic compound |
| 12/31/2008 | EP2008654A1 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amides |
| 12/31/2008 | EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 12/31/2008 | EP1406867B1 Thiolalkyl benzoic acid derivatives |
| 12/31/2008 | EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 12/31/2008 | CN101336230A Pharmaceutical for use in the treatment of ureterolithiasis |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/31/2008 | CN101332235A Magnolia bark and processing technique |
| 12/31/2008 | CN101332190A Sugar-free type citrulline effervescence tablet and preparation method thereof |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |